You Position: Home > Journal issue
Acta Pharmaceutica Sinica
2023:
2022:
2021:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2020:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2019:
- Issue 1 |
- Issue 2 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2018:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2017:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2016:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2015:
2008:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2007:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2006:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2005:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2004:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2003:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2002:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2001:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2000:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
1999:
1998:
Acta Pharmaceutica Sinica
1
Therapeutic prospect of tetrandrine against SARS-CoV-2 based on its pulmonary pharmacology and exposure character
Acta Pharmaceutica Sinica, Volume 56, Issue 7,2021, Pages 1769-1777, doi:10.16438/j.0513-4870.2021-0594
2
Qualitative and quantitative analysis of aristolochic acid components in nine Chinese medicinal materials containing toxic aristolochic substances
Acta Pharmaceutica Sinica, Volume 56, Issue 7,2021, Pages 1980-1987, doi:10.16438/j.0513-4870.2021-0142
3
The upregulation mechanism of OCT4 signaling by ID1 in colorectal cancer
Acta Pharmaceutica Sinica, Volume 56, Issue 7,2021, Pages 1945-1952, doi:10.16438/j.0513-4870.2021-0160
4
Cloning and expression analysis of RcUDPGTs genes in Tibetan Rhodiola crenulata
Acta Pharmaceutica Sinica, Volume 56, Issue 7,2021, Pages 2015-2024, doi:10.16438/j.0513-4870.2021-0082
5
Synthesis and antibacterial activity of C-7 haloacyl cephalosporins
Acta Pharmaceutica Sinica, Volume 56, Issue 7,2021, Pages 1965-1975, doi:10.16438/j.0513-4870.2021-0337